Difference between revisions of "Imetelstat (Rytelo)"
Jump to navigation
Jump to search
(Created page with "[http://www.geron.com/imetelstat link to company website] Category:Investigational Category:Telomerase inhibitors") |
m |
||
Line 1: | Line 1: | ||
− | [http://www.geron.com/imetelstat | + | ==Mechanism of action== |
+ | A lipid-conjugated oligonucleotide inhibitor of human telomerase. | ||
+ | [http://www.geron.com/imetelstat Link to company website] | ||
+ | |||
+ | ==Preliminary data== | ||
+ | # '''Abstract:''' Kebede Begna, Rebecca R. Laborde, Mrinal M Patnaik, Terra L Lasho, Darci Zblewski, Christy Finke, Lauren Schimek, Betsy R. LaPlant, Curtis A. Hanson, Monic J. Stuart, Animesh Pardanani. Imetelstat, a Telomerase Inhibitor, Induces Morphologic and Molecular Remissions In Myelofibrosis and Reversal Of Bone Marrow Fibrosis. Blood Nov 2013,122(21)662 [http://bloodjournal.hematologylibrary.org/content/122/21/662 link to original abstract] | ||
[[Category:Investigational]] | [[Category:Investigational]] | ||
[[Category:Telomerase inhibitors]] | [[Category:Telomerase inhibitors]] |
Revision as of 16:02, 11 June 2014
Mechanism of action
A lipid-conjugated oligonucleotide inhibitor of human telomerase. Link to company website
Preliminary data
- Abstract: Kebede Begna, Rebecca R. Laborde, Mrinal M Patnaik, Terra L Lasho, Darci Zblewski, Christy Finke, Lauren Schimek, Betsy R. LaPlant, Curtis A. Hanson, Monic J. Stuart, Animesh Pardanani. Imetelstat, a Telomerase Inhibitor, Induces Morphologic and Molecular Remissions In Myelofibrosis and Reversal Of Bone Marrow Fibrosis. Blood Nov 2013,122(21)662 link to original abstract